Ledaborbactam etzadroxil

Phase 1Small molecule

Basilea Pharmaceutica

Ledaborbactam etzadroxil is one of 4 small molecule programs targeting FDC. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

FDCRecruiting

FDCPhase 1

Recruiting

Competition

Competitive Landscape

4 competitors in FDC

#DrugCompanyPhaseTrials

Nexium

DDexcel Pharma Technologies Ltd.

Phase 1

1 2

Amoxicillin-Clavulanate

IIterum Therapeutics, International Limited

Phase 1

1 3

Cedax

BBurke Medical Research Institute

Phase 1

1 4

Ledaborbactam etzadroxil

Basilea Pharmaceutica

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Phase 1Recruiting

FDC

NCT06733675

Clinical

Trials by Indication[1]

Female1 trial

Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age

Completed· Basilea Pharmaceutica logo

Basilea Pharmaceutica·Phase 1·NCT06665555·34 enrolled

FDC1 trial

A Phase 1, Open-label Study to Evaluate the Safety and to Characterize the Pharmacokinetics of a Fixed-Dose Combination Formulation of Ceftibuten-Ledaborbactam Etzadroxil

Recruiting· Basilea Pharmaceutica logo

Basilea Pharmaceutica·Phase 1·NCT06733675·96 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Ledaborbactam etzadroxil. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ledaborbactam etzadroxil compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ledaborbactam etzadroxil. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Basilea Pharmaceutica company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: Basilea Pharmaceutica

Ledaborbactam etzadroxil

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Female1 trial

FDC1 trial

References

Drug Info

Quick Facts

Related News